NCT06231563: Ketamine for Veterans With Parkinson's Disease
- State
- Under way
- Phase
- Phase 2
- People
- 80 planned
- Started
- 1 Mar 2026
- Primary completion
- 30 Sep 2029
- Arms
- Ketamine
- Results
- None posted
- 30 Jan 2024: Trial registered
- 1 Mar 2026: Trial started
A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.
Kind of treatment: Drug.
Also known as 0.2 mg/kg ketamine, 1st perfusion of ketamine, 2nd perfusion of ketamine, Anaket v, Calypsol, CLORKETAM 1000, IMALGENE 1000, Intranasal Ketamine (IN), Intranasal ketamine, Ketafol component ketamine, KETASOL 100, Ketamine Infusion, Narketan, Tekam, Ursotamin, Vetaket.
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.